Frontlight ResearchEarly access
Trial site
Richmond VA Medical Center
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Liver cirrhosis2 trials
- Alzheimer disease1 trial
- Crohn's disease1 trial
- Heart failure1 trial
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Multiple myeloma1 trial
- Spinal cord injury1 trial
- Stroke1 trial
- Ulcerative colitis1 trial
- Vascular dementia1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Recruiting6 trials
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Abivax S.A.2 trials
- Bausch Health Americas, Inc.1 trial
- Exact Sciences Corporation1 trial
- Genfit1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Alzheimer disease1 recruiting
- Crohn's disease1 recruiting
- Multiple myeloma1 recruiting
- Spinal cord injury1 recruiting
- Vascular dementia1 recruiting
Closed trials
Terminated
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026